PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 19183107-10 2009 Furthermore, up-regulation of TfR expression in leukemia cells by iron chelator deferoxamine resulted in a further increase in antisense effect (up to 79% Bcl-2 reduction in K562 at the mRNA level) and in caspase-dependent apoptosis (by approximately 3-fold) by Tf-LN. Deferoxamine 80-92 BCL2 apoptosis regulator Homo sapiens 155-160 20127174-7 2010 Bcl-2 down-regulation as well as anoikis enhancement by curcumin were inhibited by superoxide anion scavenger, Mn(III)tetrakis(4-benzoic acid) porphyrin chloride, but were unaffected by other ROS scavengers including catalase and deferoxamine, suggesting that superoxide anion is a key player in the downregulation of Bcl-2 by curcumin. Deferoxamine 230-242 BCL2 apoptosis regulator Homo sapiens 0-5 12614281-8 2003 Addition of antioxidants (deferoxamine or 2-methyaminochroman) to the storage solution suppressed mitochondrial pore opening and swelling, Bcl-2 to Bax ratio increase, cytochrome C translocation, caspase-3 activation as well as rewarming-induced apoptosis. Deferoxamine 26-38 BCL2 apoptosis regulator Homo sapiens 139-144 17671763-5 2007 DFO induced apoptosis of activated HSCs, which was associated with decreasing Bcl-2 expression and the release of cytochrome c from the mitochondria to the cytosol with enhanced caspase-3 activity. Deferoxamine 0-3 BCL2 apoptosis regulator Homo sapiens 78-83 16519769-6 2006 Furthermore, Bax expression increased together with p53 and p21(WAF1/CIP1), while the Bcl-2 expression decreased in the immortalized and malignant keratinocytes treated with DFO. Deferoxamine 174-177 BCL2 apoptosis regulator Homo sapiens 86-91 34636157-5 2021 In vitro biomolecular experiments showed that by crosslinking grafted polyethylene glycol acrylate liposomes loaded with DFO, the functional electrospun fibers can release DFO locally to activate Hif-1 in BMSCs, which can regulate the balance of Bcl-2/Bax to protect mitochondria and upregulate the expression of VEGF to reconstruct microcirculation. Deferoxamine 121-124 BCL2 apoptosis regulator Homo sapiens 246-251 12529982-6 2002 Deferoxamine mesylate induced a small increase in the endogenous expression of both the bcl-2 and bax genes in the MCF-7 cells and this can be prevented by ferric chloride. Deferoxamine 0-21 BCL2 apoptosis regulator Homo sapiens 88-93 34988167-16 2021 DFO significantly increased the expression level of Bcl-2, and reduced the expression level of Bad. Deferoxamine 0-3 BCL2 apoptosis regulator Homo sapiens 52-57 34636157-5 2021 In vitro biomolecular experiments showed that by crosslinking grafted polyethylene glycol acrylate liposomes loaded with DFO, the functional electrospun fibers can release DFO locally to activate Hif-1 in BMSCs, which can regulate the balance of Bcl-2/Bax to protect mitochondria and upregulate the expression of VEGF to reconstruct microcirculation. Deferoxamine 172-175 BCL2 apoptosis regulator Homo sapiens 246-251 30246777-6 2018 We also found that the protein and mRNA levels of Bax, p53, and Fas dose-dependently increased in DFO-treated K562 cells, while the level of Bcl-2 markedly decreased in a dose-dependent manner. Deferoxamine 98-101 BCL2 apoptosis regulator Homo sapiens 141-146 34126102-4 2021 Deferoxamine-mediated suppression of apoptosis correlated with the level of pro-apoptotic Bcl-2 family proteins Bax, Bid, and Puma, which stimulate mitochondrial apoptotic pathway through permeabilization of the outer mitochondrial membrane and cytochrome c release. Deferoxamine 0-12 BCL2 apoptosis regulator Homo sapiens 90-95